Livmarli (maralixibat)

pCPA File Number: 22506
Negotiation Status:
Under consideration for negotiation
Indication(s):
Alagille syndrome
Sponsor/Manufacturer:
Mirum Pharmaceuticals Inc.
CDA-AMC Project Number:
SR0780-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable